Delaware Court of Chancery Patent Ownership Dispute Addresses Jurisdiction for Pharmaceutical Companies

Start
A litigation regarding patent ownership rights is heating up in the Delaware Court of Chancery, a court of equity that is an atypical forum for pharmaceutical company and intellectual property disputes. CyDex Pharmaceuticals, Inc. (CyDex) filed a breach of contract action against Bexson Biomedical, Inc. (Bexson) on August 28, 2024, seeking a judgment that it co-owns Bexson’s recent patent and related applications, and specific performance assigning such ownership rights to CyDex….
By: DLA Piper
Previous Story

Astellas Case Highlights Patent Eligibility Under Section 101 and the Party Presentation Principle

Next Story

Silvergate Pharmaceuticals v. Bionpharma: The Relevance of Offers of Confidential Access Under the Hatch-Waxman Statute and Awards for Attorney Fees